Oneness Biotech Co

Oneness Biotech Co Interest Coverage

The Interest Coverage Ratio of Oneness Biotech Co (4743.TWO) as of Nov 2, 2026 is -5.14. In the previous year, Interest Coverage Ratio was -4.81 — a change of 6.96% (lower).

Interest Coverage

-5.14

YoY

6.96%

Last updated:

Interest Coverage Ratio of Oneness Biotech Co is 2024 -5.14 . Interest Coverage Ratio of Oneness Biotech Co was 2023 -4.81 . It decreases by 6.96% lower compared to the previous year.

The Oneness Biotech Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-7.14 TWD
Jan 1, 2018
-2.24 TWD
Jan 1, 2019
-13.77 TWD
Jan 1, 2020
-0.58 TWD
Jan 1, 2021
-2.45 TWD
Jan 1, 2022
0.67 TWD
Jan 1, 2023
-4.81 TWD
Jan 1, 2024
-5.14 TWD
The Oneness Biotech Co Interest Coverage history
YEARInterest CoverageYoY
-5.14+6.96%
-4.81-821.56%
0.67-127.25%
-2.45+323.92%
-0.58-95.81%
-13.77+514.24%
-2.24-68.61%
-7.14+511.82%
-1.17-99.99%
-8,100.67+2.32 M%
-0.35—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oneness Biotech Co Stock analysis

What does Oneness Biotech Co do? Oneness Biotech Co., Ltd. generates revenue through the research and development of new drugs and the sale of pharmaceutical products and health products. The company focuses on health supplies, health food, and healthy food as its main products, which are distributed domestically. It also develops new drugs for treating chronic diabetic foot ulcers and anticancer drugs, targeting the domestic market for both its existing and new product lines. The firm's primary customers are domestic consumers seeking health and pharmaceutical solutions, including those requiring wound healing treatments for diabetic foot ulcers and anticancer therapies. Its product portfolio includes health supplies, health food, healthy food, and specialized drug developments, all sold within Taiwan's domestic market. Oneness Biotech's business model centers on developing and selling health and pharmaceutical products, with a particular emphasis on niche medical applications like diabetic foot ulcer treatments and cancer drugs. The company leverages its domestic distribution network to reach consumers interested in health-focused solutions and specialized medical treatments. Oneness Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oneness Biotech Co stock

Interest Coverage Ratio of Oneness Biotech Co is -5.14 in 2024.

Interest Coverage Ratio of Oneness Biotech Co changed from -4.81 to -5.14, representing a 6.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Oneness Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Oneness Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Oneness Biotech Co

All Key Metrics — Oneness Biotech Co